4.3 Article

Oral fluids that detect cardiovascular disease biomarkers

Journal

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.oooo.2012.03.003

Keywords

-

Funding

  1. National Institutes of Health [P20 RR020145, U01 DE017793, M01-RR02602]
  2. University of Kentucky General Clinical Research Core
  3. Clinical Translational Science Award [UL1RR033173]

Ask authors/readers for more resources

Objective. The aim of this study was to determine the utility of oral fluids for assessment of coronary and cardiovascular (CV) health. Study Design. Twenty-nine patients with preexisting CV disease underwent an invasive cardiac procedure (alcohol septal ablation or percutaneous coronary intervention) and provided unstimulated whole saliva (UWS), sublingual swabs (LS), gingival swabs (GS) and serum at 0, 8, 16, 24, and 48 hours. Concentrations of 13 relevant biomarkers were determined and correlated with levels in serum and the oral fluids. Results. Concentrations of the majority of biomarkers were higher in UWS than in LS and GS. Coronary and CV disease biomarkers in UWS correlated better with serum than with LS and GS based on group status and measures of time effect. Seven biomarkers demonstrated time effect changes consistent with serum biomarkers, including C-reactive protein and troponin I. Conclusions. Changes in serum biomarker profiles are reflected in oral fluids suggesting that oral fluid biomarkers could aid in the assessment of cardiac ischemia/necrosis. (Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114:207-214)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available